Literature DB >> 18983304

Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation.

H Michur1, K Maślanka, A Szczepiński, B Mariańska.   

Abstract

Reticulated platelets (RP) are the youngest forms of platelets in blood and reflect the rate of bone marrow platelet production. In the present study, we used flow cytometric analysis to determine the percentage of RPs in patients undergoing allogeneic stem cell transplantation. We investigated 10 patients after transplantation from HLA identical siblings: five with acute myeloid leukemia (AML), four with chronic myeloid leukemia (CML), and one patient with myelodysplastic syndrome (MDS). Of the patients examined, four patients underwent allogeneic bone marrow transplantation and six patients underwent peripheral blood stem cell transplantation. It was observed that the initially reduced percentage of RPs (2.9 +/- 1.7%; mean +/- SD) was significantly higher (P = 0.0109) in all patients (13.6 +/- 6.4%) in the following 10-26 days. The RP percentage peak preceded the recovery of peripheral platelet count up to 45.6 x 10(9)/l on average by 3 days. We found no difference in RP% between the AML and CML patients but we did observe that in CML patients the RP percentage increased on average 7 days earlier than in AML patients. The elevated RP percentage reflects increased bone marrow regeneration and can be considered an additional marker of thrombopoietic recovery in the patients undergoing allogeneic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983304     DOI: 10.1111/j.1751-553X.2007.00993.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  5 in total

1.  Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation.

Authors:  Mikiko Sakuragi; Satoru Hayashi; Miho Maruyama; Tomoko Kiyokawa; Keisuke Nagamine; Jiro Fujita; Tetsuo Maeda; Hisashi Kato; Hirokazu Kashiwagi; Yuzuru Kanakura; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2017-10-12       Impact factor: 2.490

Review 2.  Management of thrombocytopenia in advanced liver disease.

Authors:  V G R Gangireddy; P C Kanneganti; S Sridhar; S Talla; T Coleman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09-15

3.  Role of platelet function and platelet membrane glycoproteins in children with primary immune thrombocytopenia.

Authors:  Wen-Jun Liu; Jing Bai; Qu-Lian Guo; Zhe Huang; Hong Yang; Yong-Qi Bai
Journal:  Mol Med Rep       Date:  2016-07-11       Impact factor: 2.952

4.  The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia.

Authors:  Hanne Fredly; Elisabeth Ersvær; Astrid Olsnes Kittang; Galina Tsykunova; Bjørn Tore Gjertsen; Oystein Bruserud
Journal:  Clin Epigenetics       Date:  2013-08-01       Impact factor: 6.551

5.  Immature platelet fraction measured on the Sysmex XN hemocytometer predicts thrombopoietic recovery after autologous stem cell transplantation.

Authors:  Noreen van der Linden; Lieke J J Klinkenberg; Steven J R Meex; Erik A M Beckers; Norbert C J de Wit; Lenneke Prinzen
Journal:  Eur J Haematol       Date:  2014-04-25       Impact factor: 2.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.